DXPE vs SRPT · P/E 18, rev $1.10B vs rev $1.13B
DXP Enterprises Inc (DXPE) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
DXP Enterprises Inc (DXPE) is a industrial distribution company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported DXPE revenue for 2026-06-30 was $1.10B. Net income was $48.7M. DXPE currently screens at market cap $1.38B and trailing P/E 18.3.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
DXPE currently screens at market cap $1.38B and trailing P/E 18.3. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the DXPE and SRPT stock pages for the full models.
Not investment advice.